drugset / Trial / NCT01548638

Effect of Galantamine on Smoking Abstinence

NCT01548638

Phase 2 Completed 13 enrolled University of Pennsylvania
NaSingle-groupOpen-labelTreatment

Summary

This is a preliminary open-label study to determine whether a medication called galantamine (Brand Name: Razadyne) will help smokers quit and whether it reduces cognitive problems that smokers experience during a quit attempt.

Timeline

Start
2012-02
Primary completion
2012-08
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Galantamine Small molecule 16 mg

Indications